Cherrystone portfolio company loaned $1M through Mass. program

CHERRYSTONE ANGEL GROUP portfolio company Windgap Medical has received a $999,696 loan from the Massachusetts Life Sciences Center to further its development of a compact and easy-to-use Epi-Pen.
CHERRYSTONE ANGEL GROUP portfolio company Windgap Medical has received a $999,696 loan from the Massachusetts Life Sciences Center to further its development of a compact and easy-to-use Epi-Pen.
(Updated 10:19 a.m.) SOMERVILLE, Mass. – A Cherrystone Angel Group portfolio company, Windgap Medical Inc., was awarded nearly $1 million through a Massachusetts Life Sciences Center accelerator loan program. The medical device company, based in Somerville, Mass., is developing a compact and easy-to-use epinephrine autoinjector – often referred to as an EpiPen – for the…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -